InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Blasticidin | Serine-linked PARP1 auto-modification controls PARP inhibitor response. | 2021 | Nat Commun. | Prokhorova E. et al. | DOI: 10.1038/s41467-021-24361-9 |
| Hygromycin B Gold | Serine-linked PARP1 auto-modification controls PARP inhibitor response. | 2021 | Nat Commun. | Prokhorova E. et al. | DOI: 10.1038/s41467-021-24361-9 |
| Puromycin | Development of a B-cell maturation antigen-specific T-cell antigen coupler re... | 2021 | Cytotherapy | Bezverbnaya K. et al. | DOI: 10.1016/j.jcyt.2021.05.007 |
| Normocin™ - Antimicrobial Reagent | Development of a B-cell maturation antigen-specific T-cell antigen coupler re... | 2021 | Cytotherapy | Bezverbnaya K. et al. | DOI: 10.1016/j.jcyt.2021.05.007 |
| NF-κB and NLRP3 inflammasome inhibitor - BAY 11-7082 | Interleukin-1α (IL-1α) is a Central Regulator of Leukocyte-Endothelial Adhesi... | 2021 | Circulation | Schunk S.J. et al. | DOI: 10.1161/CIRCULATIONAHA.121.053547 |
| Poly(I:C) HMW | Zebrafish otud6b Negatively Regulates Antiviral Responses by Suppressing K63-... | 2021 | J Immunol. | Zhou Z. et al. | DOI: 10.4049/jimmunol.2000891 |
| Recombinant human TNF-α | Cyclic tensile strain affects the response of human periodontal ligament stro... | 2021 | Clin Oral Investig. | Zhao Z. et al. | DOI: 10.1007/s00784-021-04039-8 |
| Normocin™ - Antimicrobial Reagent | Vocal Fold Fibroblasts in Reinke's Edema Show Alterations Involved in Extrace... | 2021 | Biomedicines | Grill M. et al. | DOI: 10.3390/biomedicines9070735 |
| Zeocin™ | Spatial organization of FcγR and TLR2/1 on phagosome membranes differentially... | 2021 | Sci Rep. | Li W. et al. | DOI: 10.1038/s41598-021-92910-9 |
| RAW-Blue™ Cells | Spatial organization of FcγR and TLR2/1 on phagosome membranes differentially... | 2021 | Sci Rep. | Li W. et al. | DOI: 10.1038/s41598-021-92910-9 |
| QUANTI-Blue™ | Spatial organization of FcγR and TLR2/1 on phagosome membranes differentially... | 2021 | Sci Rep. | Li W. et al. | DOI: 10.1038/s41598-021-92910-9 |
| Pam3CSK4 Biotin | Spatial organization of FcγR and TLR2/1 on phagosome membranes differentially... | 2021 | Sci Rep. | Li W. et al. | DOI: 10.1038/s41598-021-92910-9 |
| Normocin™ - Antimicrobial Reagent | Spatial organization of FcγR and TLR2/1 on phagosome membranes differentially... | 2021 | Sci Rep. | Li W. et al. | DOI: 10.1038/s41598-021-92910-9 |
| Pam3CSK4 | Toll-like receptor 2 induces pathogenicity in Th17 cells and reveals a role f... | 2021 | Cell Rep. | Marks K.E. et al. | DOI: 10.1016/j.celrep.2021.109303 |
| FSL-1 | Toll-like receptor 2 induces pathogenicity in Th17 cells and reveals a role f... | 2021 | Cell Rep. | Marks K.E. et al. | DOI: 10.1016/j.celrep.2021.109303 |
| Imiquimod VacciGrade™ | Central Nervous System-Endogenous TLR7 and TLR9 Induce Different Immune Respo... | 2021 | Front Neurosci. | Storgaard Dieu R. et al. | DOI: 10.3389/fnins.2021.685645 |
| ODN 1585 VacciGrade™ | Central Nervous System-Endogenous TLR7 and TLR9 Induce Different Immune Respo... | 2021 | Front Neurosci. | Storgaard Dieu R. et al. | DOI: 10.3389/fnins.2021.685645 |
| Normocin™ - Antimicrobial Reagent | Anti-Inflammatory Potential of Simvastatin Loaded Nanoliposomes in 2D and 3D ... | 2021 | Nanomedicine | Rakshit M. et al. | DOI: 10.1016/j.nano.2021.102434 |
| THP1-Blue™ NF-κB Cells | Anti-Inflammatory Potential of Simvastatin Loaded Nanoliposomes in 2D and 3D ... | 2021 | Nanomedicine | Rakshit M. et al. | DOI: 10.1016/j.nano.2021.102434 |
| Normocin™ - Antimicrobial Reagent | Targeted Chemotherapy of Glioblastoma Spheroids with an Iontronic Pump. | 2021 | Adv Mater Technol. | Waldherr L. et al. | DOI: 10.1002/admt.202001302 |